Cardiothoracic Department, "Azienda Sanitaria Universitaria Integrata" of Udine, Italy.
Cardiothoracic Department, "Azienda Sanitaria Universitaria Integrata" of Udine, Italy.
Int J Cardiol. 2017 Dec 15;249:112-118. doi: 10.1016/j.ijcard.2017.09.025. Epub 2017 Sep 13.
Although octogenarians constitute a fast-growing portion of cardiovascular patients, few data are available on the outcome of patients aged ≥85 years with ST-Elevation Myocardial Infarction (STEMI).
We analyzed 126 consecutive patients aged ≥85 years (age 88±2 years) with STEMI, undergoing primary percutaneous coronary intervention (pPCI) within 12 hours from symptoms onset. Long-term follow-up (median 898 days) was obtained for the 102 patients surviving the index-hospitalization. In-hospital mortality rate was 19%. Nonagenarians, diabetes mellitus, severe left ventricular systolic dysfunction and intra-aortic balloon pumping were significantly and independently correlated to in-hospital mortality at the multivariate analysis. A low rate of complications was detected. Among patients surviving the index hospitalization, 32 (31%) patients died during follow-up. 55 patients (54%) had re-hospitalization due to cardiovascular causes. The univariate analysis identified chronic renal failure, Killip class ≥ 3, TIMI Risk Score >8 and very high risk of bleeding as predictors of long-term overall mortality. At the multivariate analysis only chronic renal failure and very high risk of bleeding were significantly and independently correlated to long-term all-cause mortality. Renal function and anterior myocardial infarction were significantly and independently associated with the combined end-point of cardiac mortality and re-hospitalization due to cardiovascular disease at the multivariate analysis.
PPCI in patients ≥85 years old is relatively safe. In this population, pPCI is associated with a good long-term survival, although still worse than in younger patients, despite a considerable incidence of re-hospitalization due to cardiovascular events.
虽然 80 岁以上的患者在心血管病患者中所占比例增长迅速,但关于年龄≥85 岁的 ST 段抬高型心肌梗死(STEMI)患者的预后数据却很少。
我们分析了 126 例连续的年龄≥85 岁(年龄 88±2 岁)的 STEMI 患者,这些患者在症状发作后 12 小时内行直接经皮冠状动脉介入治疗(pPCI)。对 102 例在指数住院期间存活的患者进行了长期随访(中位数 898 天)。住院期间死亡率为 19%。多元分析显示,高龄(≥90 岁)、糖尿病、严重左心室收缩功能障碍和主动脉内球囊反搏与住院期间死亡率显著相关。并发症发生率较低。在指数住院期间存活的患者中,32 例(31%)患者在随访期间死亡。55 例(54%)患者因心血管原因再次住院。单因素分析确定慢性肾功能衰竭、Killip 分级≥3、TIMI 风险评分>8 和极高出血风险是长期全因死亡率的预测因素。多因素分析仅发现慢性肾功能衰竭和极高出血风险与长期全因死亡率显著相关。肾功能和前壁心肌梗死与多因素分析中的心脏死亡率和心血管疾病再住院的联合终点显著相关。
pPCI 在年龄≥85 岁的患者中相对安全。在该人群中,pPCI 与较好的长期生存率相关,尽管与年轻患者相比仍然较差,但仍有相当比例的心血管事件再住院。